Handelsbanken Fonder’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Handelsbanken Fonder’s Portfolio MORF Stock Details MORF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-12,500	Closed	-$426K	–	1533
2024 Q2	$426K	Buy	12,500 +1,000	+9%	+$29.6K	﹤0.01%	1224
2024 Q1	$405K	Buy	11,500 +2,100	+22%	+$70.4K	﹤0.01%	1260
2023 Q4	$271K	Buy	+9,400	New	+$224K	﹤0.01%	1416
2023 Q3	–	Sell	-5,300	Closed	-$304K	–	1585
2023 Q2	$304K	Buy	+5,300	New	+$277K	﹤0.01%	1340
2022 Q1	–	Sell	-4,700	Closed	-$223K	–	1730
2021 Q4	$223K	Buy	+4,700	New	+$252K	﹤0.01%	1682

Other funds holding MORF

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Hoey Investments Coatesville, Pennsylvania $774M AUM 27.34% 1-Year Est. Return

Handelsbanken Fonder's MORF Position: Q3 2024 in Review

Handelsbanken Fonder sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 12,500 shares — an estimated $426K sold.

Handelsbanken Fonder first reported a position in MORF in Q4 2021 and held it in 5 quarters. The position peaked at $426K in Q2 2024. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

Handelsbanken Fonder reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Handelsbanken Fonder sold 12,500 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $426K.
Handelsbanken Fonder first reported a position in Morphic Holding, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
Handelsbanken Fonder's Morphic Holding, Inc. Common Stock position peaked at $426K in Q2 2024.
2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.